Literature DB >> 1560208

Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression.

J A Turpin1, M Vargo, M S Meltzer.   

Abstract

Vitamin A and other retinoids have profound effects on macrophage differentiation and function. Such effects could alter interactions between HIV and tissue macrophages, a principal target cell and reservoir for virus during HIV disease. Indeed, retinoids are used to treat various symptoms associated with HIV infection. We show that levels of virus replication in monocytes cultured 7 days before and continuously after HIV infection in 1 to 10 microM retinoic acid were 10- to 20-fold greater than those of control cells. No direct toxicity (detachment from substrate or cell death) was evident in infected or control monocytes treated with less than or equal to 10 microM retinoic acid. Maximum effects of retinoic acid (50% maximum effect was at 0.8 +/- 0.1 microM) required 5 to 7 days treatment before infection and persisted without additional treatment through more than 4 wk. RT activity in cultures of retinoic acid-treated monocytes reached maximum levels much earlier than those of control cultures, but the minimum tissue culture infectious doses for retinoic acid-treated and untreated monocytes were comparable. Retinoic acid treatment did not affect susceptibility of monocytes to HIV infection. Further, the frequency of infected cells in retinoic acid-treated and control cultures were also comparable: about 20% of cells in each culture expressed HIV proteins or RNA 2 wk after infection. In contrast, levels of HIV-specific RNA and DNA were 3- to 5-fold higher in the retinoic acid-treated over control monocytes 1 wk after infection. That retinoic acid increased levels of HIV gene expression in monocyte cultures without affecting the number of infected cells per culture suggested a transcriptional mechanism for the effect. This was confirmed in the U937 myeloid cell line transfected with HIV LTR linked to a chloramphenicol acetyl transferase reporter gene. Chloramphenicol acetyl transferase activity in lysates of retinoic acid-treated cells were 20-fold higher than that of control cells. These data show that retinoic acid significantly increased HIV replication in monocytes through mechanisms related to cell differentiation and to a direct transcriptional effect on viral gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560208

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.

Authors:  Natalia Guerra-Pérez; Ines Frank; Filippo Veglia; Meropi Aravantinou; Diana Goode; James L Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

2.  Vitamin A levels and human immunodeficiency virus load in injection drug users.

Authors:  R D Semba; H Farzadegan; D Vlahov
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Counter-intuitive plasma vitamin D and zinc status in HIV-1-infected adults with persistent low-level viraemia after treatment initiation: a pilot case-control study.

Authors:  H Melliez; A Duhamel; O Robineau; L Bocket; I Kim; E Sauser; F Loiseleur; N Viget; A Pasquet; E Senneville; D Seguy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-24       Impact factor: 3.267

4.  Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells.

Authors:  Walter Royal; Michelle V Leander; Reid Bissonnette
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

5.  Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.

Authors:  Y Yang; J Bailey; M S Vacchio; R Yarchoan; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter.

Authors:  M O Lee; P D Hobbs; X K Zhang; M I Dawson; M Pfahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.

Authors:  J W Maciaszek; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.

Authors:  A Roulston; P Beauparlant; N Rice; J Hiscott
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Transcriptional regulation by retinoic acid of interleukin-2 alpha receptors in human B cells.

Authors:  L Bhatti; N Sidell
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.